Barinthus Biotherapeutics plc (BRNS) Stock Price History
Historical prices from 2021 to 2026
Loading 10-year price history...
BRNS Historical Performance
Short-Term Returns
BRNS Stock Price Trajectory (2021–2026)
As of May 8, 2026, Barinthus Biotherapeutics plc (BRNS) trades at $0.67, representing a -32.3% return over the past year. The stock has delivered a -95.0% total return over five years (-45.2% CAGR), reflecting challenging market conditions.
The stock reached its all-time high of $17.99 on June 30, 2021. From this peak, BRNS has corrected -96.3%, currently trading 26% below its 200-day moving average, suggesting potential weakness.
When compared to Healthcare sector peers IMVT (+96.1% 1Y), NKTX (+68.4% 1Y), and IMCR (+2.3% 1Y), BRNS has underperformed the peer group average. Compare BRNS vs IMVT →
BRNS Historical Price Data (2025–2026)
Showing 30 of 1,262 recordsLoading full history…
| Date | Open | High | Low | Close | Volume | Change % |
|---|---|---|---|---|---|---|
| 2026-05-07 | 0.66 | 0.68 | 0.66 | 0.67 | 11K | +5.51% |
| 2026-05-06 | 0.66 | 0.70 | 0.63 | 0.64 | 40K | -3.05% |
| 2026-05-05 | 0.64 | 0.68 | 0.63 | 0.66 | 17K | +3.15% |
| 2026-05-04 | 0.63 | 0.67 | 0.63 | 0.64 | 8K | -2.41% |
| 2026-05-01 | 0.63 | 0.67 | 0.63 | 0.65 | 6K | +0.11% |
| 2026-04-30 | 0.61 | 0.65 | 0.61 | 0.65 | 28K | +8.35% |
| 2026-04-29 | 0.61 | 0.63 | 0.59 | 0.60 | 11K | -1.66% |
| 2026-04-28 | 0.64 | 0.65 | 0.61 | 0.61 | 11K | -3.17% |
| 2026-04-27 | 0.63 | 0.64 | 0.59 | 0.63 | 14K | -1.87% |
| 2026-04-24 | 0.68 | 0.68 | 0.60 | 0.64 | 8K | +0.47% |
| 2026-04-23 | 0.66 | 0.68 | 0.61 | 0.64 | 25K | +2.21% |
| 2026-04-22 | 0.61 | 0.68 | 0.60 | 0.63 | 31K | +5.97% |
| 2026-04-21 | 0.59 | 0.62 | 0.59 | 0.59 | 20K | 0.00% |
| 2026-04-20 | 0.62 | 0.62 | 0.59 | 0.59 | 36K | 0.00% |
| 2026-04-17 | 0.59 | 0.62 | 0.59 | 0.59 | 15K | -0.17% |
| 2026-04-16 | 0.61 | 0.61 | 0.59 | 0.59 | 16K | -0.34% |
| 2026-04-15 | 0.59 | 0.64 | 0.59 | 0.59 | 11K | +2.76% |
| 2026-04-14 | 0.59 | 0.62 | 0.55 | 0.58 | 35K | +4.93% |
| 2026-04-13 | 0.58 | 0.60 | 0.55 | 0.55 | 28K | -3.08% |
| 2026-04-10 | 0.60 | 0.60 | 0.55 | 0.57 | 20K | +3.18% |
| 2026-04-09 | 0.56 | 0.56 | 0.55 | 0.55 | 10K | -0.02% |
| 2026-04-08 | 0.55 | 0.61 | 0.55 | 0.55 | 21K | +1.68% |
| 2026-04-07 | 0.54 | 0.62 | 0.54 | 0.54 | 21K | -4.85% |
| 2026-04-06 | 0.58 | 0.62 | 0.55 | 0.57 | 8K | -5.23% |
| 2026-04-02 | 0.57 | 0.62 | 0.54 | 0.60 | 19K | +11.09% |
| 2026-04-01 | 0.54 | 0.57 | 0.54 | 0.54 | 7K | -5.08% |
| 2026-03-31 | 0.58 | 0.59 | 0.55 | 0.57 | 4K | -1.90% |
| 2026-03-30 | 0.52 | 0.59 | 0.52 | 0.58 | 4K | +5.45% |
| 2026-03-27 | 0.58 | 0.59 | 0.54 | 0.55 | 5K | +0.04% |
| 2026-03-26 | 0.55 | 0.55 | 0.55 | 0.55 | 5K | -0.04% |
See BRNS's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs BRNS Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare BRNS vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonBRNS — Frequently Asked Questions
Quick answers to the most common questions about buying BRNS stock.
How has BRNS stock performed recently?
BRNS declined -32.3% over the past year, below its 5-year annualized CAGR of -45.2%. The stock trades below its 200-day moving average, reflecting the downtrend.
What is BRNS's all-time high price?
Barinthus Biotherapeutics plc reached $17.99 on 2021-06-30. The 52-week high is $2.92. Current 1-year return of -32.3% places the stock further from historical peaks.
Where can I download BRNS historical price data?
This page provides BRNS daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 2021-2026, downloadable in CSV format.